Design Therapeutics, Inc.
DSGNDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Aug 6, 2026
26dMarket Overview
Stock performance and key metrics
3 upcoming, 0 past
How DSGN's past catalysts played out
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Design Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Design Therapeutics, Inc.'s (DSGN) pipeline across Phase 2. Its lead program is DT-216P2 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Design Therapeutics, Inc.'s next FDA catalyst?→
Design Therapeutics, Inc.'s (DSGN) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track DSGN biotech catalysts?→
Add DSGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Design Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.